Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Metabolic Response
100%
NSCLC Patients
100%
Residual Metabolic Activity
100%
Response Assessment
75%
Multivariate Model
50%
SUVmax
50%
FDG-PET Scan
50%
Residual Disease
50%
Overall Treatment Time
50%
Post-radiotherapy
50%
Local Survival
50%
Patient Identification
25%
Tumor
25%
Area under the Curve
25%
Chemoradiotherapy
25%
Radiation Dose
25%
Radiotherapy
25%
Clinical Data
25%
Patients at Risk
25%
Overall Survival
25%
Patient Characteristics
25%
Univariate Analysis
25%
Therapeutic Approaches
25%
Prediction Model
25%
Clinical Treatment
25%
Primary Outcome Measure
25%
Patient Selection
25%
Metabolic
25%
Treatment Information
25%
Leave-one-out
25%
Primary Tumor
25%
Treatment Prediction
25%
3D Conformal
25%
Gross Tumor Volume
25%
Standardized Uptake Value
25%
Early Identification
25%
Patient Treatment
25%
Patient Tumor
25%
Medical Patients
25%
Electronic Health Record System
25%
Local Control
25%
Demographic Data
25%
Local Failure
25%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
25%
Prescribed Dose
25%
Active Area
25%
Additional Therapy
25%
Complete Metabolic Response
25%
Tumor Factor
25%
Equivalent Radiation
25%
Resected NSCLC
25%
Treatment Factors
25%
Twice a Day
25%
Patient Charts
25%
Nursing and Health Professions
Positron Emission Tomography-Computed Tomography
100%
Maximum Standardized Uptake Value
100%
Neoplasm
66%
X-Ray Computed Tomography
66%
Minimal Residual Disease
66%
Radiotherapy
66%
Area under the Curve
33%
Univariate Analysis
33%
Overall Survival
33%
Chemoradiotherapy
33%
Primary Tumor
33%
Radiation Dose
33%
Gross Tumor Volume
33%
Electronic Medical Record System
33%
Fluorodeoxyglucose
33%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Neoplasm
100%
Non-Small Cell Lung Cancer
100%
Minimal Residual Disease
66%
Radiation Therapy
66%
Overall Survival
33%
Univariate Analysis
33%
Primary Tumor
33%
Chemoradiotherapy
33%
Standardized Uptake Value
33%
Fluorodeoxyglucose
33%
Cross-Validation
33%
Electronic Patient Record
33%
INIS
patients
100%
prediction
100%
tumors
36%
assessments
27%
positron computed tomography
27%
diseases
18%
radiotherapy
18%
multivariate analysis
18%
cat scanning
18%
data
9%
doses
9%
curves
9%
validation
9%
values
9%
volume
9%
combined therapy
9%
therapy
9%
control
9%
risks
9%
comparative evaluations
9%
computed tomography
9%
failures
9%
uptake
9%
charts
9%
medical records
9%
fluorodeoxyglucose
9%
equivalent radiation doses
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Minimal Residual Disease
66%
Polyethylene Terephthalate
66%
Overall Survival
33%
Primary Tumor
33%
Chemoradiation Therapy
33%
Cross-Validation
33%
Fluorodeoxyglucose
33%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
66%
Overall Survival
33%
Gross Tumor Volume
33%
Electronic Medical Record System
33%